Pure Global AI
NCT06340906Not yet recruiting

Electroacupuncture in Symptom Management After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

University of California, IrvineClinicalTrials.govother
Verified
Study focus
Disease/Condition
Cancer
Drug/Device/Intervention
Electroacupuncture
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
University of California, Irvine
Location
Irvine, United States of America
Timeline & enrollment
Phase
N/A
Start date
May 15, 2024
End date
Jan 30, 2026
Enrollment
20 participants
Primary outcome

Feasibility in utilizing an EA for patients who have undergone Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy - Number of Patients Recruited,Feasibility in utilizing an EA for patients who have undergone Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy - Patient Recruitment Rate,Feasibility in utilizing an EA for patients who have undergone Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy - Reasons for Abstaining from Participation,Feasibility in utilizing an EA for patients who have undergone Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy - Recruitment Duration,Feasibility in utilizing an EA for patients who have undergone Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy - Number of Completed Electroacupuncture Sessions,Feasibility in utilizing an EA for patients who have undergone Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy - Proportion of Completed Electroacupuncture Sessions

Summary

The investigators are conducting this research study is to evaluate the feasibility
 (recruitment, compliance, safety, and acceptance) of using electroacupuncture (EA) to manage
 complex symptoms such as pain, nausea/vomiting, diarrhea, and insomnia in patients who have
 undergone Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Additionally,
 the investigators are aiming to determine the effectiveness of EA in reducing these symptoms,
 and to examine how EA impacts important biomarkers, or proteins in the blood, that can be
 used as indicators or signs of these symptoms.

ICD-10 classifications
Carcinoid syndromeOther chemotherapyCarcinoma in situ, unspecifiedMalignant neoplasmsMalignant neoplasm: Prepuce
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06340906
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06340906 through Pure Global AI's free database. This phase not specified trial is sponsored by University of California, Irvine and is currently Not yet recruiting. The study focuses on Cancer. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.